首页 > 最新文献

European Radiology最新文献

英文 中文
We may be closer to automated Kellgren-Lawrence grading for knee osteoarthritis than we thought. 我们可能比想象中更接近于对膝关节骨关节炎进行凯尔格伦-劳伦斯自动分级。
IF 4.7 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-09-19 DOI: 10.1007/s00330-024-11064-0
Yin Xi, Avneesh Chhabra
{"title":"We may be closer to automated Kellgren-Lawrence grading for knee osteoarthritis than we thought.","authors":"Yin Xi, Avneesh Chhabra","doi":"10.1007/s00330-024-11064-0","DOIUrl":"https://doi.org/10.1007/s00330-024-11064-0","url":null,"abstract":"","PeriodicalId":12076,"journal":{"name":"European Radiology","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142282503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deep learning reconstruction algorithm and high-concentration contrast medium: feasibility of a double-low protocol in coronary computed tomography angiography. 深度学习重建算法和高浓度造影剂:冠状动脉计算机断层扫描血管造影双低方案的可行性。
IF 4.7 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-09-19 DOI: 10.1007/s00330-024-11059-x
Damiano Caruso, Domenico De Santis, Giuseppe Tremamunno, Curzio Santangeli, Tiziano Polidori, Giovanna G Bona, Marta Zerunian, Antonella Del Gaudio, Luca Pugliese, Andrea Laghi

Objective: To evaluate radiation dose and image quality of a double-low CCTA protocol reconstructed utilizing high-strength deep learning image reconstructions (DLIR-H) compared to standard adaptive statistical iterative reconstruction (ASiR-V) protocol in non-obese patients.

Materials and methods: From June to October 2022, consecutive patients, undergoing clinically indicated CCTA, with BMI < 30 kg/m2 were prospectively included and randomly assigned into three groups: group A (100 kVp, ASiR-V 50%, iodine delivery rate [IDR] = 1.8 g/s), group B (80 kVp, DLIR-H, IDR = 1.4 g/s), and group C (80 kVp, DLIR-H, IDR = 1.2 g/s). High-concentration contrast medium was administered. Image quality analysis was evaluated by two radiologists. Radiation and contrast dose, and objective and subjective image quality were compared across the three groups.

Results: The final population consisted of 255 patients (64 ± 10 years, 161 men), 85 per group. Group B yielded 42% radiation dose reduction (2.36 ± 0.9 mSv) compared to group A (4.07 ± 1.2 mSv; p < 0.001) and achieved a higher signal-to-noise ratio (30.5 ± 11.5), contrast-to-noise-ratio (27.8 ± 11), and subjective image quality (Likert scale score: 4, interquartile range: 3-4) compared to group A and group C (all p ≤ 0.001). Contrast medium dose in group C (44.8 ± 4.4 mL) was lower than group A (57.7 ± 6.2 mL) and B (50.4 ± 4.3 mL), all the comparisons were statistically different (all p < 0.001).

Conclusion: DLIR-H combined with 80-kVp CCTA with an IDR 1.4 significantly reduces radiation and contrast medium exposure while improving image quality compared to conventional 100-kVp with 1.8 IDR protocol in non-obese patients.

Clinical relevance statement: Low radiation and low contrast medium dose coronary CT angiography protocol is feasible with high-strength deep learning reconstruction and high-concentration contrast medium without compromising image quality.

Key points: Minimizing the radiation and contrast medium dose while maintaining CT image quality is highly desirable. High-strength deep learning iterative reconstruction protocol yielded 42% radiation dose reduction compared to conventional protocol. "Double-low" coronary CTA is feasible with high-strength deep learning reconstruction without compromising image quality in non-obese patients.

目的评估利用高强度深度学习图像重建(DLIR-H)重建的双低CCTA方案与标准自适应统计迭代重建(ASiR-V)方案在非肥胖患者中的辐射剂量和图像质量:从2022年6月到10月,对接受临床指征CCTA的BMI为2的连续患者进行前瞻性纳入,并随机分配到三组:A组(100 kVp,ASiR-V 50%,碘给药率[IDR] = 1.8 g/s)、B组(80 kVp,DLIR-H,IDR = 1.4 g/s)和C组(80 kVp,DLIR-H,IDR = 1.2 g/s)。使用高浓度造影剂。图像质量分析由两名放射科医生进行评估。比较了三组的辐射和造影剂剂量、客观和主观图像质量:最终共有 255 名患者(64 ± 10 岁,161 名男性),每组 85 人。与 A 组(4.07±1.2 mSv;P 结论)相比,B 组的辐射剂量减少了 42% (2.36±0.9 mSv):在非肥胖患者中,DLIR-H 结合 IDR 为 1.4 的 80 kVp CCTA 与传统的 IDR 为 1.8 的 100 kVp 相比,可显著减少辐射和造影剂暴露,同时提高图像质量:低辐射和低造影剂剂量的冠状动脉 CT 血管造影方案是可行的,可采用高强度深度学习重建和高浓度造影剂,且不会影响图像质量:在保持 CT 图像质量的同时,最大限度地减少辐射和造影剂剂量是非常理想的。高强度深度学习迭代重建方案比传统方案减少了42%的辐射剂量。在不影响图像质量的前提下,对非肥胖患者进行高强度深度学习重建可实现 "双低 "冠状动脉CTA。
{"title":"Deep learning reconstruction algorithm and high-concentration contrast medium: feasibility of a double-low protocol in coronary computed tomography angiography.","authors":"Damiano Caruso, Domenico De Santis, Giuseppe Tremamunno, Curzio Santangeli, Tiziano Polidori, Giovanna G Bona, Marta Zerunian, Antonella Del Gaudio, Luca Pugliese, Andrea Laghi","doi":"10.1007/s00330-024-11059-x","DOIUrl":"https://doi.org/10.1007/s00330-024-11059-x","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate radiation dose and image quality of a double-low CCTA protocol reconstructed utilizing high-strength deep learning image reconstructions (DLIR-H) compared to standard adaptive statistical iterative reconstruction (ASiR-V) protocol in non-obese patients.</p><p><strong>Materials and methods: </strong>From June to October 2022, consecutive patients, undergoing clinically indicated CCTA, with BMI < 30 kg/m<sup>2</sup> were prospectively included and randomly assigned into three groups: group A (100 kVp, ASiR-V 50%, iodine delivery rate [IDR] = 1.8 g/s), group B (80 kVp, DLIR-H, IDR = 1.4 g/s), and group C (80 kVp, DLIR-H, IDR = 1.2 g/s). High-concentration contrast medium was administered. Image quality analysis was evaluated by two radiologists. Radiation and contrast dose, and objective and subjective image quality were compared across the three groups.</p><p><strong>Results: </strong>The final population consisted of 255 patients (64 ± 10 years, 161 men), 85 per group. Group B yielded 42% radiation dose reduction (2.36 ± 0.9 mSv) compared to group A (4.07 ± 1.2 mSv; p < 0.001) and achieved a higher signal-to-noise ratio (30.5 ± 11.5), contrast-to-noise-ratio (27.8 ± 11), and subjective image quality (Likert scale score: 4, interquartile range: 3-4) compared to group A and group C (all p ≤ 0.001). Contrast medium dose in group C (44.8 ± 4.4 mL) was lower than group A (57.7 ± 6.2 mL) and B (50.4 ± 4.3 mL), all the comparisons were statistically different (all p < 0.001).</p><p><strong>Conclusion: </strong>DLIR-H combined with 80-kVp CCTA with an IDR 1.4 significantly reduces radiation and contrast medium exposure while improving image quality compared to conventional 100-kVp with 1.8 IDR protocol in non-obese patients.</p><p><strong>Clinical relevance statement: </strong>Low radiation and low contrast medium dose coronary CT angiography protocol is feasible with high-strength deep learning reconstruction and high-concentration contrast medium without compromising image quality.</p><p><strong>Key points: </strong>Minimizing the radiation and contrast medium dose while maintaining CT image quality is highly desirable. High-strength deep learning iterative reconstruction protocol yielded 42% radiation dose reduction compared to conventional protocol. \"Double-low\" coronary CTA is feasible with high-strength deep learning reconstruction without compromising image quality in non-obese patients.</p>","PeriodicalId":12076,"journal":{"name":"European Radiology","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142282500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Added value of histogram analysis of intravoxel incoherent motion and diffusion kurtosis imaging for the evaluation of complete response to neoadjuvant therapy in locally advanced rectal cancer 体外非相干运动和弥散峰度成像直方图分析在评估局部晚期直肠癌新辅助治疗完全反应中的附加价值
IF 5.9 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-09-19 DOI: 10.1007/s00330-024-11081-z
Lan Zhang, Ziwei Jin, Fan Yang, Yiwan Guo, Yuan Liu, Manman Chen, Si Xu, Zhenyu Lin, Peng Sun, Ming Yang, Peng Zhang, Kaixiong Tao, Tao Zhang, Xin Li, Chuansheng Zheng

Objective

To evaluate how intravoxel incoherent motion (IVIM) and diffusion kurtosis imaging (DKI) histogram analysis contribute to assessing complete response (CR) to neoadjuvant therapy (NAT) in locally advanced rectal cancer (LARC).

Material and methods

In this prospective study, participants with LARC, who underwent NAT and subsequent surgery, with adequate MR image quality, were enrolled from November 2021 to March 2023. Conventional MRI (T2WI and DWI), IVIM, and DKI were performed before NAT (pre-NAT) and within two weeks before surgery (post-NAT). Image evaluation was independently performed by two experienced radiologists. Pathological complete response (pCR) was used as the reference standard. An IVIM–DKI-added model (a combination of IVIM and DKI histogram parameters with T2WI and DWI) was constructed. Receiver operating characteristic (ROC) curves were generated to evaluate the diagnostic performance of conventional MRI and the IVIM–DKI-added model.

Results

A total of 59 participants (median age: 58.00 years [IQR: 52.00, 62.00]; 38 [64%] men) were evaluated, including 21 pCR and 38 non-pCR cases. The histogram parameters of DKI, including skewness of kurtosis post-NAT (post-KSkewness) and root mean squared of change ratio of diffusivity (Δ%DDKI-root mean squared), were entered into the IVIM–DKI-added model. The area under the ROC curve (AUC) of the IVIM–DKI-added model for assessing CR to NAT was significantly higher than that of conventional MRI (0.855 [95% CI: 0.749–0.960] vs 0.685 [95% CI: 0.565–0.806], p < 0.001).

Conclusion

IVIM and DKI provide added value in the evaluation of CR to NAT in LARC.

Key Points

Question The current conventional imaging evaluation system lacks adequacy for assessing CR to NAT in LARC.

Findings Significantly improved diagnostic performance was observed with the histogram analysis of IVIM and DKI in conjunction with conventional MRI.

Clinical relevance IVIM and DKI provide significant value in evaluating CR to NAT in LARC, which bears significant implications for reducing surgical complications and facilitating organ preservation.

目的评估体素内不连贯运动(IVIM)和弥散峰度成像(DKI)直方图分析如何有助于评估局部晚期直肠癌(LARC)对新辅助治疗(NAT)的完全反应(CR)。在 NAT 前(NAT 前)和手术前两周内(NAT 后)进行了常规 MRI(T2WI 和 DWI)、IVIM 和 DKI 检查。图像评估由两名经验丰富的放射科医生独立完成。病理完全反应(pCR)作为参考标准。建立了 IVIM-DKI 添加模型(IVIM 和 DKI 直方图参数与 T2WI 和 DWI 的组合)。结果 共评估了 59 名参与者(中位年龄:58.00 岁 [IQR:52.00,62.00];38 [64%]名男性),包括 21 例 pCR 和 38 例非 pCR 病例。DKI的直方图参数,包括NAT后的峰度偏斜度(post-KSkewness)和扩散率变化比的均方根(Δ%DKI-均方根),都被输入到IVIM-DKI-附加模型中。IVIM-DKI-added 模型评估 CR 至 NAT 的 ROC 曲线下面积 (AUC) 明显高于传统 MRI(0.855 [95% CI: 0.749-0.960] vs 0.685 [95% CI: 0.565-0.806], p < 0.001)。临床意义 IVIM 和 DKI 在评估 LARC 中 NAT 的 CR 方面具有重要价值,对减少手术并发症和促进器官保存具有重要意义。
{"title":"Added value of histogram analysis of intravoxel incoherent motion and diffusion kurtosis imaging for the evaluation of complete response to neoadjuvant therapy in locally advanced rectal cancer","authors":"Lan Zhang, Ziwei Jin, Fan Yang, Yiwan Guo, Yuan Liu, Manman Chen, Si Xu, Zhenyu Lin, Peng Sun, Ming Yang, Peng Zhang, Kaixiong Tao, Tao Zhang, Xin Li, Chuansheng Zheng","doi":"10.1007/s00330-024-11081-z","DOIUrl":"https://doi.org/10.1007/s00330-024-11081-z","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Objective</h3><p>To evaluate how intravoxel incoherent motion (IVIM) and diffusion kurtosis imaging (DKI) histogram analysis contribute to assessing complete response (CR) to neoadjuvant therapy (NAT) in locally advanced rectal cancer (LARC).</p><h3 data-test=\"abstract-sub-heading\">Material and methods</h3><p>In this prospective study, participants with LARC, who underwent NAT and subsequent surgery, with adequate MR image quality, were enrolled from November 2021 to March 2023. Conventional MRI (T2WI and DWI), IVIM, and DKI were performed before NAT (pre-NAT) and within two weeks before surgery (post-NAT). Image evaluation was independently performed by two experienced radiologists. Pathological complete response (pCR) was used as the reference standard. An IVIM–DKI-added model (a combination of IVIM and DKI histogram parameters with T2WI and DWI) was constructed. Receiver operating characteristic (ROC) curves were generated to evaluate the diagnostic performance of conventional MRI and the IVIM–DKI-added model.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>A total of 59 participants (median age: 58.00 years [IQR: 52.00, 62.00]; 38 [64%] men) were evaluated, including 21 pCR and 38 non-pCR cases. The histogram parameters of DKI, including skewness of kurtosis post-NAT (post-<i>K</i><sub>Skewness</sub>) and root mean squared of change ratio of diffusivity (Δ%<i>D</i><sub>DKI-root mean squared</sub>), were entered into the IVIM–DKI-added model. The area under the ROC curve (AUC) of the IVIM–DKI-added model for assessing CR to NAT was significantly higher than that of conventional MRI (0.855 [95% CI: 0.749–0.960] vs 0.685 [95% CI: 0.565–0.806], <i>p</i> &lt; 0.001).</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>IVIM and DKI provide added value in the evaluation of CR to NAT in LARC.</p><h3 data-test=\"abstract-sub-heading\">Key Points</h3><p><b><i>Question</i></b> <i>The current conventional imaging evaluation system lacks adequacy for assessing CR to NAT in LARC</i>.</p><p><b><i>Findings</i></b> <i>Significantly improved diagnostic performance was observed with the histogram analysis of IVIM and DKI in conjunction with conventional MRI</i>.</p><p><b><i>Clinical relevance</i></b> <i>IVIM and DKI provide significant value in evaluating CR to NAT in LARC, which bears significant implications for reducing surgical complications and facilitating organ preservation</i>.</p>","PeriodicalId":12076,"journal":{"name":"European Radiology","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142264660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Site effects in multisite fetal brain MRI: morphological insights into early brain development. 多部位胎儿脑磁共振成像的部位效应:早期大脑发育的形态学启示。
IF 4.7 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-09-19 DOI: 10.1007/s00330-024-11084-w
Xinyi Xu, Cong Sun, Hong Yu, Guohui Yan, Qingqing Zhu, Xianglei Kong, Yibin Pan, Haoan Xu, Tianshu Zheng, Chi Zhou, Yutian Wang, Jiaxin Xiao, Ruike Chen, Mingyang Li, Songying Zhang, Hongjie Hu, Yu Zou, Jingshi Wang, Guangbin Wang, Dan Wu

Objective: To evaluate multisite effects on fetal brain MRI. Specifically, to identify crucial acquisition factors affecting fetal brain structural measurements and developmental patterns, while assessing the effectiveness of existing harmonization methods in mitigating site effects.

Materials and methods: Between May 2017 and March 2022, T2-weighted fast spin-echo sequences in-utero MRI were performed on healthy fetuses from retrospectively recruited pregnant volunteers on four different scanners at four sites. A generalized additive model (GAM) was used to quantitatively assess site effects, including field strength (FS), manufacturer (M), in-plane resolution (R), and slice thickness (ST), on subcortical volume and cortical morphological measurements, including cortical thickness, curvature, and sulcal depth. Growth models were selected to elucidate the developmental trajectories of these morphological measurements. Welch's test was performed to evaluate the influence of site effects on developmental trajectories. The comBat-GAM harmonization method was applied to mitigate site-related biases.

Results: The final analytic sample consisted of 340 MRI scans from 218 fetuses (mean GA, 30.1 weeks ± 4.4 [range, 21.7-40 weeks]). GAM results showed that lower FS and lower spatial resolution led to overestimations in selected brain regions of subcortical volumes and cortical morphological measurements. Only the peak cortical thickness in developmental trajectories was significantly influenced by the effects of FS and R. Notably, ComBat-GAM harmonization effectively removed site effects while preserving developmental patterns.

Conclusion: Our findings pinpointed the key acquisition factors in in-utero fetal brain MRI and underscored the necessity of data harmonization when pooling multisite data for fetal brain morphology investigations.

Key points: Question How do specific site MRI acquisition factors affect fetal brain imaging? Finding Lower FS and spatial resolution overestimated subcortical volumes and cortical measurements. Cortical thickness in developmental trajectories was influenced by FS and in-plane resolution. Clinical relevance This study provides important guidelines for the fetal MRI community when scanning fetal brains and underscores the necessity of data harmonization of cross-center fetal studies.

目的评估多部位对胎儿脑部磁共振成像的影响。具体而言,确定影响胎儿大脑结构测量和发育模式的关键采集因素,同时评估现有的协调方法在减轻部位效应方面的有效性:2017年5月至2022年3月期间,在四个地点的四台不同的扫描仪上对回顾性招募的怀孕志愿者的健康胎儿进行了T2加权快速自旋回波序列宫内磁共振成像。采用广义相加模型(GAM)定量评估了场强(FS)、制造商(M)、面内分辨率(R)和切片厚度(ST)等部位对皮质下容积和皮质形态测量(包括皮质厚度、曲率和沟深)的影响。选择生长模型是为了阐明这些形态测量值的发育轨迹。韦尔奇检验用于评估部位效应对发育轨迹的影响。采用 comBat-GAM 协调方法来减轻与地点有关的偏差:最终的分析样本包括来自 218 个胎儿(平均孕期为 30.1 周 ± 4.4 [范围为 21.7-40 周])的 340 个磁共振成像扫描。GAM结果显示,较低的FS和较低的空间分辨率导致高估了选定脑区的皮质下体积和皮质形态测量值。值得注意的是,ComBat-GAM 协调有效地消除了部位效应,同时保留了发育模式:我们的研究结果指出了宫内胎儿脑部磁共振成像的关键采集因素,并强调了在汇集多部位数据进行胎儿脑部形态学研究时数据协调的必要性:问题 特定部位磁共振成像采集因素如何影响胎儿脑成像?结果 较低的FS和空间分辨率高估了皮层下体积和皮层测量值。发育轨迹中的皮层厚度受 FS 和平面内分辨率的影响。临床意义 这项研究为胎儿磁共振成像界提供了扫描胎儿大脑的重要指南,并强调了跨中心胎儿研究数据协调的必要性。
{"title":"Site effects in multisite fetal brain MRI: morphological insights into early brain development.","authors":"Xinyi Xu, Cong Sun, Hong Yu, Guohui Yan, Qingqing Zhu, Xianglei Kong, Yibin Pan, Haoan Xu, Tianshu Zheng, Chi Zhou, Yutian Wang, Jiaxin Xiao, Ruike Chen, Mingyang Li, Songying Zhang, Hongjie Hu, Yu Zou, Jingshi Wang, Guangbin Wang, Dan Wu","doi":"10.1007/s00330-024-11084-w","DOIUrl":"https://doi.org/10.1007/s00330-024-11084-w","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate multisite effects on fetal brain MRI. Specifically, to identify crucial acquisition factors affecting fetal brain structural measurements and developmental patterns, while assessing the effectiveness of existing harmonization methods in mitigating site effects.</p><p><strong>Materials and methods: </strong>Between May 2017 and March 2022, T2-weighted fast spin-echo sequences in-utero MRI were performed on healthy fetuses from retrospectively recruited pregnant volunteers on four different scanners at four sites. A generalized additive model (GAM) was used to quantitatively assess site effects, including field strength (FS), manufacturer (M), in-plane resolution (R), and slice thickness (ST), on subcortical volume and cortical morphological measurements, including cortical thickness, curvature, and sulcal depth. Growth models were selected to elucidate the developmental trajectories of these morphological measurements. Welch's test was performed to evaluate the influence of site effects on developmental trajectories. The comBat-GAM harmonization method was applied to mitigate site-related biases.</p><p><strong>Results: </strong>The final analytic sample consisted of 340 MRI scans from 218 fetuses (mean GA, 30.1 weeks ± 4.4 [range, 21.7-40 weeks]). GAM results showed that lower FS and lower spatial resolution led to overestimations in selected brain regions of subcortical volumes and cortical morphological measurements. Only the peak cortical thickness in developmental trajectories was significantly influenced by the effects of FS and R. Notably, ComBat-GAM harmonization effectively removed site effects while preserving developmental patterns.</p><p><strong>Conclusion: </strong>Our findings pinpointed the key acquisition factors in in-utero fetal brain MRI and underscored the necessity of data harmonization when pooling multisite data for fetal brain morphology investigations.</p><p><strong>Key points: </strong>Question How do specific site MRI acquisition factors affect fetal brain imaging? Finding Lower FS and spatial resolution overestimated subcortical volumes and cortical measurements. Cortical thickness in developmental trajectories was influenced by FS and in-plane resolution. Clinical relevance This study provides important guidelines for the fetal MRI community when scanning fetal brains and underscores the necessity of data harmonization of cross-center fetal studies.</p>","PeriodicalId":12076,"journal":{"name":"European Radiology","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142282502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incremental prognostic value of left atrial strain in apical hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study 心尖肥厚型心肌病左心房应变的增量预后价值:心血管磁共振研究
IF 5.9 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-09-18 DOI: 10.1007/s00330-024-11058-y
Yun Tang, Xuan Ma, Jiaxin Wang, Shujuan Yang, Zhixiang Dong, Xiuyu Chen, Kankan Zhao, Zhuxin Wei, Jing Xu, Yanyan Song, Xiaorui Xiang, Chen Cui, Yanjie Zhu, Kai Yang, Shihua Zhao

Objectives

This study aimed to evaluate the prognostic value of left atrial (LA) strain in patients with apical hypertrophic cardiomyopathy (ApHCM), as assessed by cardiac magnetic resonance (CMR) imaging.

Methods

Four hundred and five consecutive patients with ApHCM who underwent CMR examination were retrospectively included. The study endpoint included all-cause death, heart transplant, aborted sudden cardiac death, hospitalization for heart failure, stroke, and new-onset atrial fibrillation (AF).

Results

After a median follow-up of 97 months, 75 patients (18.5%) reached the endpoint. Patients were divided into two groups based on the median LA reservoir strain of 29.4%. The group with lower LA reservoir strain had thicker maximum wall thickness, greater late gadolinium enhancement extent, and smaller end-diastolic volume index, stroke volume index, and cardiac index (all p < 0.02). For LA parameters, this subgroup showed greater diameter and volume index and worse ejection fraction, reservoir, conduit, and booster strain (all p < 0.001). In the multivariable model, age (HR 1.88, 95% CI: 1.06–3.31, p = 0.030), baseline AF (HR 2.95, 95% CI: 1.64–5.28, p < 0.001), LA volume index (LAVi) (HR 2.07, 95% CI: 1.21–3.55, p = 0.008) and LA reservoir strain (HR 2.82, 95% CI: 1.51–5.26, p = 0.001) were all associated with the outcome. Adding LAVi and LA reservoir strain in turn to the multivariable model (age and baseline AF) resulted in significant improvements in model performance (p < 0.001).

Conclusion

In ApHCM patients, LA reservoir strain is independently associated with cardiovascular risk events and has an incremental prognostic value.

Clinical relevance statement

Left atrial reservoir strain measured by cardiac magnetic resonance is highly correlated with the prognosis of apical hypertrophic cardiomyopathy and has potential incremental value in the prognosis of major adverse cardiac events.

Key Points

  • Left atrial (LA) strain parameters may be useful for risk stratification and treatment of apical hypertrophic cardiomyopathy (ApHCM).

  • Apical hypertrophic cardiomyopathy (ApHCM) is independently associated with LA morphology and function.

  • Cardiac MR examination, especially its feature-tracking technology, provides the possibility to prognosticate ApHCM at an early stage.

Graphical Abstract

目的 本研究旨在评估心脏磁共振(CMR)成像评估的心尖肥厚型心肌病(ApHCM)患者左心房(LA)应变的预后价值。研究终点包括全因死亡、心脏移植、心源性猝死、心力衰竭住院、中风和新发心房颤动(房颤)。结果中位随访 97 个月后,75 名患者(18.5%)达到终点。根据 LA 储库应变的中位数 29.4% 将患者分为两组。LA储层应变较低的一组患者最大壁厚较厚,晚期钆增强程度较大,舒张末期容积指数、每搏容积指数和心脏指数较小(所有P均为0.02)。就 LA 参数而言,该亚组显示出更大的直径和容积指数,更差的射血分数、储血池、导管和增压应变(所有 p 均为 0.001)。在多变量模型中,年龄(HR 1.88,95% CI:1.06-3.31,p = 0.030)、基线房颤(HR 2.95,95% CI:1.64-5.28,p <0.001)、LA容积指数(LAVi)(HR 2.07,95% CI:1.21-3.55,p = 0.008)和LA储腔应变(HR 2.82,95% CI:1.51-5.26,p = 0.001)均与结果相关。在多变量模型(年龄和基线房颤)中依次加入 LAVi 和 LA 储腔应变可显著改善模型性能(p < 0.001)。临床意义声明:心脏磁共振测量的左心房储腔应变与心尖肥厚型心肌病的预后高度相关,在重大不良心脏事件的预后中具有潜在的增量价值。要点左心房(LA)应变参数可能有助于心尖肥厚型心肌病(ApHCM)的风险分层和治疗。心尖肥厚型心肌病(ApHCM)与 LA 形态和功能独立相关。心脏磁共振检查,尤其是其特征追踪技术,为早期预后 ApHCM 提供了可能。
{"title":"Incremental prognostic value of left atrial strain in apical hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study","authors":"Yun Tang, Xuan Ma, Jiaxin Wang, Shujuan Yang, Zhixiang Dong, Xiuyu Chen, Kankan Zhao, Zhuxin Wei, Jing Xu, Yanyan Song, Xiaorui Xiang, Chen Cui, Yanjie Zhu, Kai Yang, Shihua Zhao","doi":"10.1007/s00330-024-11058-y","DOIUrl":"https://doi.org/10.1007/s00330-024-11058-y","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Objectives</h3><p>This study aimed to evaluate the prognostic value of left atrial (LA) strain in patients with apical hypertrophic cardiomyopathy (ApHCM), as assessed by cardiac magnetic resonance (CMR) imaging.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>Four hundred and five consecutive patients with ApHCM who underwent CMR examination were retrospectively included. The study endpoint included all-cause death, heart transplant, aborted sudden cardiac death, hospitalization for heart failure, stroke, and new-onset atrial fibrillation (AF).</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>After a median follow-up of 97 months, 75 patients (18.5%) reached the endpoint. Patients were divided into two groups based on the median LA reservoir strain of 29.4%. The group with lower LA reservoir strain had thicker maximum wall thickness, greater late gadolinium enhancement extent, and smaller end-diastolic volume index, stroke volume index, and cardiac index (all <i>p</i> &lt; 0.02). For LA parameters, this subgroup showed greater diameter and volume index and worse ejection fraction, reservoir, conduit, and booster strain (all <i>p</i> &lt; 0.001). In the multivariable model, age (HR 1.88, 95% CI: 1.06–3.31, <i>p</i> = 0.030), baseline AF (HR 2.95, 95% CI: 1.64–5.28, <i>p</i> &lt; 0.001), LA volume index (LAVi) (HR 2.07, 95% CI: 1.21–3.55, <i>p</i> = 0.008) and LA reservoir strain (HR 2.82, 95% CI: 1.51–5.26, <i>p</i> = 0.001) were all associated with the outcome. Adding LAVi and LA reservoir strain in turn to the multivariable model (age and baseline AF) resulted in significant improvements in model performance (<i>p</i> &lt; 0.001).</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>In ApHCM patients, LA reservoir strain is independently associated with cardiovascular risk events and has an incremental prognostic value.</p><h3 data-test=\"abstract-sub-heading\">Clinical relevance statement</h3><p>Left atrial reservoir strain measured by cardiac magnetic resonance is highly correlated with the prognosis of apical hypertrophic cardiomyopathy and has potential incremental value in the prognosis of major adverse cardiac events.</p><h3 data-test=\"abstract-sub-heading\">Key Points</h3><ul>\u0000<li>\u0000<p><i>Left atrial (LA) strain parameters may be useful for risk stratification and treatment of apical hypertrophic cardiomyopathy (ApHCM).</i></p>\u0000</li>\u0000<li>\u0000<p><i>Apical hypertrophic cardiomyopathy (ApHCM) is independently associated with LA morphology and function.</i></p>\u0000</li>\u0000<li>\u0000<p><i>Cardiac MR examination, especially its feature-tracking technology, provides the possibility to prognosticate ApHCM at an early stage.</i></p>\u0000</li>\u0000</ul><h3 data-test=\"abstract-sub-heading\">Graphical Abstract</h3>","PeriodicalId":12076,"journal":{"name":"European Radiology","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142269416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting post-lung transplant survival in systemic sclerosis using CT-derived features from preoperative chest CT scans 利用术前胸部 CT 扫描的 CT 衍生特征预测系统性硬化症患者肺移植后的存活率
IF 5.9 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-09-18 DOI: 10.1007/s00330-024-11077-9
Jatin Singh, Grant Kokenberger, Lucas Pu, Ernest Chan, Alaa Ali, Kaveh Moghbeli, Tong Yu, Chadi A. Hage, Pablo G. Sanchez, Jiantao Pu

Objectives

The current understanding of survival prediction of lung transplant (LTx) patients with systemic sclerosis (SSc) is limited. This study aims to identify novel image features from preoperative chest CT scans associated with post-LTx survival in SSc patients and integrate them into comprehensive prediction models.

Materials and methods

We conducted a retrospective study based on a cohort of SSc patients with demographic information, clinical data, and preoperative chest CT scans who underwent LTx between 2004 and 2020. This cohort consists of 102 patients (mean age, 50 years ± 10, 61% (62/102) females). Five CT-derived body composition features (bone, skeletal muscle, visceral, subcutaneous, and intramuscular adipose tissues) and three CT-derived cardiopulmonary features (heart, arteries, and veins) were automatically computed using 3-D convolutional neural networks. Cox regression was used to identify post-LTx survival factors, generate composite prediction models, and stratify patients based on mortality risk. Model performance was assessed using the area under the receiver operating characteristics curve (ROC-AUC).

Results

Muscle mass ratio, bone density, artery–vein volume ratio, muscle volume, and heart volume ratio computed from CT images were significantly associated with post-LTx survival. Models using only CT-derived features outperformed all state-of-the-art clinical models in predicting post-LTx survival. The addition of CT-derived features improved the performance of traditional models at 1-year, 3-year, and 5-year survival prediction with maximum AUC scores of 0.77 (0.67–0.86), 0.85 (0.77–0.93), and 0.90 (95% CI: 0.83–0.97), respectively.

Conclusion

The integration of CT-derived features with demographic and clinical features can significantly improve t post-LTx survival prediction and identify high-risk SSc patients.

Key Points

Question What CT features can predict post-lung-transplant survival for SSc patients?

Finding CT body composition features such as muscle mass, bone density, and cardiopulmonary volumes significantly predict survival.

Clinical relevance Our individualized risk assessment tool can better guide clinicians in choosing and managing patients requiring lung transplant for systemic sclerosis.

Graphical Abstract

目的目前对系统性硬化症(SSc)肺移植(LTx)患者生存预测的了解还很有限。本研究旨在从术前胸部 CT 扫描中找出与 SSc 患者肺移植术后存活率相关的新图像特征,并将其整合到综合预测模型中。材料和方法我们对 2004 年至 2020 年期间接受肺移植术的 SSc 患者队列进行了回顾性研究,这些患者具有人口统计学信息、临床数据和术前胸部 CT 扫描。该队列由 102 名患者组成(平均年龄为 50 岁 ± 10 岁,61%(62/102)为女性)。使用三维卷积神经网络自动计算了五个 CT 导出的身体成分特征(骨骼、骨骼肌、内脏、皮下和肌内脂肪组织)和三个 CT 导出的心肺特征(心脏、动脉和静脉)。Cox 回归用于确定 LTx 后的生存因素、生成复合预测模型并根据死亡风险对患者进行分层。结果从 CT 图像计算出的肌肉质量比、骨密度、动脉-静脉容积比、肌肉容积和心脏容积比与 LTx 术后生存率显著相关。在预测 LTx 术后存活率方面,仅使用 CT 导出特征的模型优于所有最先进的临床模型。结论CT特征与人口统计学特征和临床特征的整合能明显改善LTx术后生存预测并识别高风险SSc患者。临床意义 我们的个体化风险评估工具能更好地指导临床医生选择和管理需要肺移植的系统性硬化症患者。
{"title":"Predicting post-lung transplant survival in systemic sclerosis using CT-derived features from preoperative chest CT scans","authors":"Jatin Singh, Grant Kokenberger, Lucas Pu, Ernest Chan, Alaa Ali, Kaveh Moghbeli, Tong Yu, Chadi A. Hage, Pablo G. Sanchez, Jiantao Pu","doi":"10.1007/s00330-024-11077-9","DOIUrl":"https://doi.org/10.1007/s00330-024-11077-9","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Objectives</h3><p>The current understanding of survival prediction of lung transplant (LTx) patients with systemic sclerosis (SSc) is limited. This study aims to identify novel image features from preoperative chest CT scans associated with post-LTx survival in SSc patients and integrate them into comprehensive prediction models.</p><h3 data-test=\"abstract-sub-heading\">Materials and methods</h3><p>We conducted a retrospective study based on a cohort of SSc patients with demographic information, clinical data, and preoperative chest CT scans who underwent LTx between 2004 and 2020. This cohort consists of 102 patients (mean age, 50 years ± 10, 61% (62/102) females). Five CT-derived body composition features (bone, skeletal muscle, visceral, subcutaneous, and intramuscular adipose tissues) and three CT-derived cardiopulmonary features (heart, arteries, and veins) were automatically computed using 3-D convolutional neural networks. Cox regression was used to identify post-LTx survival factors, generate composite prediction models, and stratify patients based on mortality risk. Model performance was assessed using the area under the receiver operating characteristics curve (ROC-AUC).</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Muscle mass ratio, bone density, artery–vein volume ratio, muscle volume, and heart volume ratio computed from CT images were significantly associated with post-LTx survival. Models using only CT-derived features outperformed all state-of-the-art clinical models in predicting post-LTx survival. The addition of CT-derived features improved the performance of traditional models at 1-year, 3-year, and 5-year survival prediction with maximum AUC scores of 0.77 (0.67–0.86), 0.85 (0.77–0.93), and 0.90 (95% CI: 0.83–0.97), respectively.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>The integration of CT-derived features with demographic and clinical features can significantly improve t post-LTx survival prediction and identify high-risk SSc patients.</p><h3 data-test=\"abstract-sub-heading\">Key Points</h3><p><b><i>Question</i></b> <i>What CT features can predict post-lung-transplant survival for SSc patients</i>?</p><p><b><i>Finding</i></b> <i>CT body composition features such as muscle mass, bone density, and cardiopulmonary volumes significantly predict survival</i>.</p><p><b><i>Clinical relevance</i></b> <i>Our individualized risk assessment tool can better guide clinicians in choosing and managing patients requiring lung transplant for systemic sclerosis</i>.</p><h3 data-test=\"abstract-sub-heading\">Graphical Abstract</h3>","PeriodicalId":12076,"journal":{"name":"European Radiology","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142264658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world response assessment of immune checkpoint inhibition: comparing iRECIST and RECIST 1.1 in melanoma and non-small cell lung cancer patients 免疫检查点抑制剂的真实反应评估:黑色素瘤和非小细胞肺癌患者的 iRECIST 和 RECIST 1.1 比较
IF 5.9 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-09-18 DOI: 10.1007/s00330-024-11060-4
Christian Nelles, Moritz Gräf, Pascale Bernard, Thorsten Persigehl, Nils Große Hokamp, David Zopfs, David Maintz, Nicole Kreuzberg, Jürgen Wolf, Paul J. Bröckelmann, Simon Lennartz

Objectives

To compare immune response evaluation criteria in solid tumors (iRECIST) and response evaluation criteria in solid tumors (RECIST) 1.1 for response assessment of immune checkpoint inhibitor (ICI) therapy in a real-world setting in patients with melanoma and non-small cell lung cancer (NSCLC).

Methods

Two-hundred fifty-two patients with melanoma and NSCLC who received CTLA-4 inhibitor ipilimumab or PD-1 inhibitors nivolumab or pembrolizumab and who underwent staging CT of the chest and abdomen were retrospectively included. Treatment response evaluation according to the RECIST 1.1 and iRECIST guidelines was performed for all patients. Response patterns, as well as overall response rate (ORR), disease control rate (DCR), and time to progression (TTP), were compared between RECIST 1.1 and iRECIST.

Results

Out of 143 patients with progressive disease (PD) according to RECIST 1.1, 48 (33.6%) did not attain confirmation of progression (iCPD) as per iRECIST and six patients who were treated beyond RECIST 1.1 progression reached PD at a later point in time in iRECIST, resulting in a significant difference in TTP between iRECIST and RECIST 1.1 (618.3 ± 626.9 days vs. 538.1 ± 617.9 days, respectively (p < 0.05)). The number of non-responders as per RECIST 1.1 was 79, whereas it was 60 when using iRECIST. ORR was 28.5% for RECIST 1.1 and 34.1% for iRECIST, and corresponding DCR of 67.4% for RECIST 1.1 and 74.6% for iRECIST.

Conclusion

iRECIST was more suitable than RECIST 1.1 for capturing atypical response patterns to ICI therapy in patients with melanoma and NSCLC, resulting in differences in the assessment of treatment response.

Clinical relevance statement

Compared to RECIST 1.1, iRECIST may improve patient care and treatment decisions for patients with NSCLC or melanoma who are treated with immune checkpoint inhibitors in clinical routine.

Key Points

  • RECIST 1.1 may incorrectly assess atypical treatment patterns to immune checkpoint inhibitors.

  • iRECIST better captured atypical response patterns compared to RECIST 1.1.

  • iRECIST was more suitable for assessing response to immune checkpoint inhibitors in non-small cell lung carcinoma and melanoma.

目的比较用于黑色素瘤和非小细胞肺癌 (NSCLC) 患者免疫检查点抑制剂 (ICI) 治疗反应评估的实体瘤免疫反应评估标准 (iRECIST) 和实体瘤反应评估标准 (RECIST) 1.1。方法回顾性纳入了252例黑色素瘤和NSCLC患者,这些患者接受了CTLA-4抑制剂伊匹单抗或PD-1抑制剂尼妥珠单抗或pembrolizumab治疗,并接受了胸部和腹部的分期CT检查。根据 RECIST 1.1 和 iRECIST 指南对所有患者进行了治疗反应评估。比较了 RECIST 1.1 和 iRECIST 的反应模式以及总反应率 (ORR)、疾病控制率 (DCR) 和进展时间 (TTP)。结果 在 143 例根据 RECIST 1.1 诊断为疾病进展 (PD) 的患者中,有 48 例(33.6%)未根据 iRECIST 获得疾病进展确认 (iCPD),6 例在 RECIST 1.1 进展后接受治疗的患者在 iRECIST 的较晚时间点达到 PD,导致 iRECIST 和 RECIST 1.1 的 TTP 显著不同(分别为 618.3 ± 626.9 天 vs. 538.1 ± 617.9 天 (p <0.05))。根据 RECIST 1.1,无应答者为 79 人,而使用 iRECIST 时为 60 人。RECIST1.1的ORR为28.5%,iRECIST为34.1%;RECIST1.1的相应DCR为67.4%,iRECIST为74.6%。结论iRECIST比RECIST1.1更适合捕捉黑色素瘤和NSCLC患者对ICI治疗的非典型反应模式,从而导致治疗反应评估的差异。iRECIST 更适合评估非小细胞肺癌和黑色素瘤患者对免疫检查点抑制剂的反应。
{"title":"Real-world response assessment of immune checkpoint inhibition: comparing iRECIST and RECIST 1.1 in melanoma and non-small cell lung cancer patients","authors":"Christian Nelles, Moritz Gräf, Pascale Bernard, Thorsten Persigehl, Nils Große Hokamp, David Zopfs, David Maintz, Nicole Kreuzberg, Jürgen Wolf, Paul J. Bröckelmann, Simon Lennartz","doi":"10.1007/s00330-024-11060-4","DOIUrl":"https://doi.org/10.1007/s00330-024-11060-4","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Objectives</h3><p>To compare immune response evaluation criteria in solid tumors (iRECIST) and response evaluation criteria in solid tumors (RECIST) 1.1 for response assessment of immune checkpoint inhibitor (ICI) therapy in a real-world setting in patients with melanoma and non-small cell lung cancer (NSCLC).</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>Two-hundred fifty-two patients with melanoma and NSCLC who received CTLA-4 inhibitor ipilimumab or PD-1 inhibitors nivolumab or pembrolizumab and who underwent staging CT of the chest and abdomen were retrospectively included. Treatment response evaluation according to the RECIST 1.1 and iRECIST guidelines was performed for all patients. Response patterns, as well as overall response rate (ORR), disease control rate (DCR), and time to progression (TTP), were compared between RECIST 1.1 and iRECIST.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Out of 143 patients with progressive disease (PD) according to RECIST 1.1, 48 (33.6%) did not attain confirmation of progression (iCPD) as per iRECIST and six patients who were treated beyond RECIST 1.1 progression reached PD at a later point in time in iRECIST, resulting in a significant difference in TTP between iRECIST and RECIST 1.1 (618.3 ± 626.9 days vs. 538.1 ± 617.9 days, respectively (<i>p</i> &lt; 0.05)). The number of non-responders as per RECIST 1.1 was 79, whereas it was 60 when using iRECIST. ORR was 28.5% for RECIST 1.1 and 34.1% for iRECIST, and corresponding DCR of 67.4% for RECIST 1.1 and 74.6% for iRECIST.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>iRECIST was more suitable than RECIST 1.1 for capturing atypical response patterns to ICI therapy in patients with melanoma and NSCLC, resulting in differences in the assessment of treatment response.</p><h3 data-test=\"abstract-sub-heading\">Clinical relevance statement</h3><p>Compared to RECIST 1.1, iRECIST may improve patient care and treatment decisions for patients with NSCLC or melanoma who are treated with immune checkpoint inhibitors in clinical routine.</p><h3 data-test=\"abstract-sub-heading\">Key Points</h3><ul>\u0000<li>\u0000<p><i>RECIST 1.1 may incorrectly assess atypical treatment patterns to immune checkpoint inhibitors.</i></p>\u0000</li>\u0000<li>\u0000<p><i>iRECIST better captured atypical response patterns compared to RECIST 1.1.</i></p>\u0000</li>\u0000<li>\u0000<p><i>iRECIST was more suitable for assessing response to immune checkpoint inhibitors in non-small cell lung carcinoma and melanoma.</i></p>\u0000</li>\u0000</ul>","PeriodicalId":12076,"journal":{"name":"European Radiology","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142264532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ESR Essentials: imaging of suspected child abuse—practice recommendations by the European Society of Paediatric Radiology ESR要点:疑似虐待儿童的成像--欧洲儿科放射学会的实践建议
IF 5.9 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-09-18 DOI: 10.1007/s00330-024-11052-4
Gabrielle C. Colleran, Maria Fossmark, Karen Rosendahl, Maria Argyropoulou, Kshitij Mankad, Amaka C. Offiah

Abstract

The goal of this paper is to provide a useful desktop reference for the imaging of suspected child abuse with clear, age-specific pathways for appropriate evidence-based imaging and follow-up.

We aim to provide a road map for the imaging evaluation and follow-up of this important and vulnerable cohort of patients presenting with signs and symptoms concerning for inflicted injury. As the imaging recommendations differ for children of different ages, we provide a flowchart of the appropriate imaging pathway for infants, toddlers, and older children, which allows ease of selection of which children should undergo skeletal survey, non-contrast computed tomography (CT) brain with 3-dimensional (D) reformats, and magnetic resonance imaging (MRI) of the brain and whole spine. For ease of review, we include a table of the common intracranial and spinal patterns of injury in abusive head trauma. We summarise search patterns, areas of review, and key findings to include in the report.

To exclude skeletal injury, infants and children under 2 years of age should undergo a full skeletal survey in accordance with national guidelines, with a limited follow-up skeletal survey performed 11–14 days later. For children over 2 years of age, the need for skeletal imaging should be decided on a case-by-case basis.

All infants should undergo a non-contrast-enhanced CT brain with 3-D reformats. If this is normal with no abnormal neurology, then no further neuroimaging is required. If this is abnormal, then they should proceed to MRI brain and whole spine within 2–5 days. Children older than 1 year of age who have abnormal neurology and/or findings on skeletal survey that are suggestive of inflicted injury should undergo non-contrast CT brain with 3-D reformats and, depending on the findings, may also require MRI of the brain and whole spine.

We hope that this will be a helpful contribution to the radiology literature, particularly for the general radiologist with low volumes of paediatrics in their practice, supporting them with managing these important cases when they arise in daily practice.

Key Points

  • The choice of initial imaging (skeletal survey and/or brain CT) depends on the age of the child in whom abuse is suspected.

  • A follow-up skeletal survey is mandatory 11–14 days after the initial survey.

  • If an MRI of the brain is performed, then an MRI of the whole spine should be performed concurrently.

本文的目的是为疑似虐待儿童的影像学检查提供有用的桌面参考资料,为适当的循证影像学检查和随访提供明确的、针对特定年龄段的路径。由于不同年龄段儿童的影像学建议不同,我们提供了一个婴儿、幼儿和较大儿童的适当影像学路径流程图,便于选择哪些儿童应进行骨骼测量、非对比度计算机断层扫描(CT)脑部三维(D)重构、磁共振成像(MRI)脑部和整个脊柱成像。为便于查阅,我们列出了虐待性头部创伤中常见的颅内和脊柱损伤模式。为排除骨骼损伤,2 岁以下婴幼儿应根据国家指南进行全面骨骼检查,并在 11-14 天后进行有限的后续骨骼检查。对于 2 岁以上的儿童,应根据具体情况决定是否需要进行骨骼成像检查。所有婴儿都应接受非对比度增强脑部 CT 检查,并进行三维重建。如果检查结果正常,且神经系统无异常,则无需进行进一步的神经成像检查。如果异常,则应在 2-5 天内进行脑部和整个脊柱的核磁共振成像检查。我们希望这篇文章能对放射学文献有所帮助,尤其是对儿科病例较少的普通放射科医生,当他们在日常工作中遇到这些重要病例时,能为他们提供帮助。要点初次成像(骨骼检查和/或脑部 CT)的选择取决于怀疑受虐儿童的年龄。初次检查后 11-14 天必须进行后续骨骼检查。
{"title":"ESR Essentials: imaging of suspected child abuse—practice recommendations by the European Society of Paediatric Radiology","authors":"Gabrielle C. Colleran, Maria Fossmark, Karen Rosendahl, Maria Argyropoulou, Kshitij Mankad, Amaka C. Offiah","doi":"10.1007/s00330-024-11052-4","DOIUrl":"https://doi.org/10.1007/s00330-024-11052-4","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Abstract</h3><p>The goal of this paper is to provide a useful desktop reference for the imaging of suspected child abuse with clear, age-specific pathways for appropriate evidence-based imaging and follow-up.</p><p>We aim to provide a road map for the imaging evaluation and follow-up of this important and vulnerable cohort of patients presenting with signs and symptoms concerning for inflicted injury. As the imaging recommendations differ for children of different ages, we provide a flowchart of the appropriate imaging pathway for infants, toddlers, and older children, which allows ease of selection of which children should undergo skeletal survey, non-contrast computed tomography (CT) brain with 3-dimensional (D) reformats, and magnetic resonance imaging (MRI) of the brain and whole spine. For ease of review, we include a table of the common intracranial and spinal patterns of injury in abusive head trauma. We summarise search patterns, areas of review, and key findings to include in the report.</p><p>To exclude skeletal injury, infants and children under 2 years of age should undergo a full skeletal survey in accordance with national guidelines, with a limited follow-up skeletal survey performed 11–14 days later. For children over 2 years of age, the need for skeletal imaging should be decided on a case-by-case basis.</p><p>All infants should undergo a non-contrast-enhanced CT brain with 3-D reformats. If this is normal with no abnormal neurology, then no further neuroimaging is required. If this is abnormal, then they should proceed to MRI brain and whole spine within 2–5 days. Children older than 1 year of age who have abnormal neurology and/or findings on skeletal survey that are suggestive of inflicted injury should undergo non-contrast CT brain with 3-D reformats and, depending on the findings, may also require MRI of the brain and whole spine.</p><p>We hope that this will be a helpful contribution to the radiology literature, particularly for the general radiologist with low volumes of paediatrics in their practice, supporting them with managing these important cases when they arise in daily practice.</p><h3 data-test=\"abstract-sub-heading\">Key Points</h3><ul>\u0000<li>\u0000<p><i>The choice of initial imaging (skeletal survey and/or brain CT) depends on the age of the child in whom abuse is suspected</i>.</p>\u0000</li>\u0000<li>\u0000<p><i>A follow-up skeletal survey is mandatory 11–14 days after the initial survey</i>.</p>\u0000</li>\u0000<li>\u0000<p><i>If an MRI of the brain is performed, then an MRI of the whole spine should be performed concurrently</i>.</p>\u0000</li>\u0000</ul>","PeriodicalId":12076,"journal":{"name":"European Radiology","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142269913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relevance of lesion size in navigator-triggered and free-breathing diffusion-weighted liver MRI 导航仪触发和自由呼吸弥散加权肝脏磁共振成像中病灶大小的相关性
IF 5.9 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-09-17 DOI: 10.1007/s00330-024-11063-1
Bianca Reithmeier, Frederik B. Laun, Tobit Führes, Michael Uder, Sebastian Bickelhaupt, Marc Saake

Objectives

The purpose of this study was to investigate the relevance of focal liver lesions (FLL) size for lesion detection comparing navigator triggering (TRIG) to free breathing (FB) liver Diffusion-weighted magnetic resonance imaging (DWI).

Materials and method

Patients with known or suspected FLL were prospectively (registry number 276_19 B) included from October to December 2019 in this study, out of which 32 had liver lesions. Echo planar spin-echo DWI data both with TRIG and FB were with approximately constant acquisition times acquired at 1.5 T. Lesions were segmented in the b = 800 s/mm² images in both the TRIG and FB images. The lesion size, location (liver segment), liver lesion visibility, as well as contrast-to-noise ratio (CNR) were recorded. The CNR was assessed with the Wilcoxon–Mann–Whitney test and the number of visible lesions with the Fisher test.

Results

Data from 43 patients (22 female) were analyzed. The mean patient age was 58 ± 14 years. A total of 885 FLL (Ntotal) were segmented. Among these, 811 lesions (Nboth) were detected with TRIG and FB, 65 lesions exclusively with TRIG (NTRIG_Only), and nine exclusively in FB (NFB_Only). The largest additional lesion in TRIG/FB had a diameter of 10.4 mm/7.6 mm. The number of additional lesions detected with TRIG decreased with size. Among all lesions ≤ 4.7 mm, the relative number of additional lesions was 15.6%. Additional lesions were found in all liver segments with TRIG. In the left liver lobe, the relative proportion was 9.2%, and in the right liver lobe 5.4%. CNR and visibility were significantly higher in TRIG than in FB (p < 0.001). In relation to size, the difference is significant in terms of visibility and CNR for lesion diameters ≤ 8 mm.

Conclusion

Respiration triggering can improve the detection of small liver lesions with diameters up to approx. 1 cm in the whole liver.

Key Points

Question Can respiration triggering (TRIG) improve the detection of small FLL compared to FB diffusion-weighted imaging?

Findings Among 885 segmented FLL, TRIG was superior to FB for lesions smaller than 8mm and had improved CNR and visibility.

Clinical relevance Diffusion-weighted magnetic resonance imaging is used for the detection of focal liver lesions and image quality is influenced by breathing motion. Navigator triggering becomes more important for smaller lesions, and seems recommendable for the detection of small focal liver lesions.

本研究的目的是比较导航仪触发(TRIG)和自由呼吸(FB)肝脏弥散加权磁共振成像(DWI),研究病灶肝脏病变(FLL)大小与病变检测的相关性。TRIG 和 FB 的回波平面自旋回波 DWI 数据均在 1.5 T 条件下以近似恒定的采集时间获得。在 TRIG 和 FB 图像的 b = 800 s/mm² 图像中对病变进行分割。记录病变大小、位置(肝段)、肝脏病变可见度以及对比-噪声比(CNR)。CNR 采用 Wilcoxon-Mann-Whitney 检验进行评估,可见病变的数量采用 Fisher 检验进行评估。患者平均年龄为 58 ± 14 岁。共分割出 885 个 FLL(Ntotal)。其中,通过 TRIG 和 FB 检测到 811 个病变(Nboth),65 个病变仅通过 TRIG 检测到(NTRIG_Only),9 个病变仅通过 FB 检测到(NFB_Only)。TRIG/FB 中最大的额外病变直径为 10.4 毫米/7.6 毫米。TRIG 检测到的额外病变数量随病变大小而减少。在所有直径小于 4.7 毫米的病变中,额外病变的相对数量为 15.6%。使用 TRIG 在所有肝段都发现了额外病灶。左肝叶的相对比例为 9.2%,右肝叶为 5.4%。TRIG 的 CNR 和能见度明显高于 FB(p <0.001)。结论呼吸触发可提高对全肝脏直径不超过约 1 厘米的小肝脏病变的检测率。要点问题与 FB 扩散加权成像相比,呼吸触发(TRIG)能否提高对小 FLL 的检测率?临床意义 扩散加权磁共振成像用于检测肝脏病灶,图像质量受呼吸运动的影响。对于较小的病灶,导航仪触发变得更加重要,因此在检测肝脏小病灶时值得推荐。
{"title":"Relevance of lesion size in navigator-triggered and free-breathing diffusion-weighted liver MRI","authors":"Bianca Reithmeier, Frederik B. Laun, Tobit Führes, Michael Uder, Sebastian Bickelhaupt, Marc Saake","doi":"10.1007/s00330-024-11063-1","DOIUrl":"https://doi.org/10.1007/s00330-024-11063-1","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Objectives</h3><p>The purpose of this study was to investigate the relevance of focal liver lesions (FLL) size for lesion detection comparing navigator triggering (TRIG) to free breathing (FB) liver Diffusion-weighted magnetic resonance imaging (DWI).</p><h3 data-test=\"abstract-sub-heading\">Materials and method</h3><p>Patients with known or suspected FLL were prospectively (registry number 276_19 B) included from October to December 2019 in this study, out of which 32 had liver lesions. Echo planar spin-echo DWI data both with TRIG and FB were with approximately constant acquisition times acquired at 1.5 T. Lesions were segmented in the <i>b</i> = 800 s/mm² images in both the TRIG and FB images. The lesion size, location (liver segment), liver lesion visibility, as well as contrast-to-noise ratio (CNR) were recorded. The CNR was assessed with the Wilcoxon–Mann–Whitney test and the number of visible lesions with the Fisher test.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Data from 43 patients (22 female) were analyzed. The mean patient age was 58 ± 14 years. A total of 885 FLL (<i>N</i><sub>total</sub>) were segmented. Among these, 811 lesions (<i>N</i><sub>both</sub>) were detected with TRIG and FB, 65 lesions exclusively with TRIG (<i>N</i><sub>TRIG_Only</sub>), and nine exclusively in FB (<i>N</i><sub>FB_Only</sub>). The largest additional lesion in TRIG/FB had a diameter of 10.4 mm/7.6 mm. The number of additional lesions detected with TRIG decreased with size. Among all lesions ≤ 4.7 mm, the relative number of additional lesions was 15.6%. Additional lesions were found in all liver segments with TRIG. In the left liver lobe, the relative proportion was 9.2%, and in the right liver lobe 5.4%. CNR and visibility were significantly higher in TRIG than in FB (<i>p</i> &lt; 0.001). In relation to size, the difference is significant in terms of visibility and CNR for lesion diameters ≤ 8 mm.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Respiration triggering can improve the detection of small liver lesions with diameters up to approx. 1 cm in the whole liver.</p><h3 data-test=\"abstract-sub-heading\">Key Points</h3><p><b><i>Question</i></b> <i>Can respiration triggering (TRIG) improve the detection of small FLL compared to FB diffusion-weighted imaging</i>?</p><p><b><i>Findings</i></b> <i>Among 885 segmented FLL, TRIG was superior to FB for lesions smaller than 8</i> <i>mm and had improved CNR and visibility</i>.</p><p><b><i>Clinical relevance</i></b> <i>Diffusion-weighted magnetic resonance imaging is used for the detection of focal liver lesions and image quality is influenced by breathing motion. Navigator triggering becomes more important for smaller lesions, and seems recommendable for the detection of small focal liver lesions</i>.</p>","PeriodicalId":12076,"journal":{"name":"European Radiology","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142264394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prognostic value of lymphovascular invasion for stage I lung adenocarcinoma based on the presence of ground-glass opacity 基于磨玻璃状混浊的 I 期肺腺癌淋巴管侵犯的预后价值
IF 5.9 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-09-16 DOI: 10.1007/s00330-024-11048-0
Jooae Choe, Sang Min Lee, Sohee Park, Sehoon Choi, Kyung-Hyun Do, Joon Beom Seo

Objectives

There is still a debate regarding the prognostic implication of lymphovascular invasion (LVI) in stage I lung adenocarcinoma. Ground-glass opacity (GGO) on CT is known to correlate with a less invasive or lepidic component in adenocarcinoma, which may influence the strength of prognostic factors. This study aimed to explore the prognostic value of LVI in stage I lung adenocarcinoma based on the presence of GGO.

Materials and methods

Stage I lung adenocarcinoma patients receiving lobectomy between 2010 and 2019 were retrospectively categorized as GGO-positive or GGO-negative (solid adenocarcinoma) on CT. Multivariable Cox regression analyses were performed for disease-free survival (DFS) and overall survival (OS) to evaluate the prognostic significance of pathologic LVI based on the presence of GGO.

Results

Of 924 patients included (mean age, 62.5 ± 9.2 years; 505 women), 525 (56.8%) exhibited GGO-positive adenocarcinoma and 116 (12.6%) were diagnosed with LVI. LVI was significantly more frequent in solid than GGO-positive adenocarcinoma (20.1% vs. 6.9%, p < 0.001). Multivariable analysis identified LVI and visceral pleural invasion (VPI) as significant prognostic factors for shorter DFS among solid adenocarcinoma patients (LVI, hazard ratio (HR): 1.89, p = 0.004; VPI, HR: 1.65, p = 0.003) but not GGO-positive patients (p = 0.76 and p = 0.87). In contrast, LVI was not a significant prognostic factor for OS in either group (p > 0.05).

Conclusion

In stage I lung adenocarcinoma, pathologic LVI was associated with DFS only in patients with solid lung adenocarcinoma.

Clinical relevance statement

Lymphovascular invasion (LVI) significantly affects disease-free survival in solid-stage I lung adenocarcinoma patients, but not those with ground-glass opacity (GGO) adenocarcinoma. Risk stratification considering both GGO on CT and LVI may identify patients benefiting from increased surveillance.

Key Points

  • The presence of ground-glass opacity portends different prognoses for lung adenocarcinoma.

  • In stage I lung adenocarcinoma, lymphovascular invasion (LVI) was significantly more frequent in solid adenocarcinomas than in ground-glass opacity (GGO)-positive adenocarcinomas.

  • LVI was not associated with overall survival in patients with either solid adenocarcinomas or GGO adenocarcinomas.

目的:关于一期肺腺癌淋巴管侵犯(LVI)对预后的影响仍存在争议。众所周知,CT 上的地玻璃不透明(GGO)与腺癌中的低侵袭性或鳞状成分相关,这可能会影响预后因素的强度。本研究旨在根据 GGO 的存在探讨 LVI 在 I 期肺腺癌中的预后价值。材料与方法回顾性地将 2010 年至 2019 年期间接受肺叶切除术的 I 期肺腺癌患者在 CT 上分为 GGO 阳性或 GGO 阴性(实变性腺癌)。对无病生存期(DFS)和总生存期(OS)进行了多变量 Cox 回归分析,以评估基于 GGO 存在的病理 LVI 的预后意义。结果 在纳入的 924 例患者中(平均年龄 62.5 ± 9.2 岁;505 例女性),525 例(56.8%)表现为 GGO 阳性腺癌,116 例(12.6%)被诊断为 LVI。LVI在实性腺癌中的发生率明显高于GGO阳性腺癌(20.1%对6.9%,p <0.001)。多变量分析发现,LVI和内脏胸膜侵犯(VPI)是实体瘤腺癌患者DFS缩短的重要预后因素(LVI,危险比(HR):1.89,p = 0.004;VPI,HR:1.65,p = 0.003),但不是GGO阳性患者的重要预后因素(p = 0.76和p = 0.87)。临床意义声明淋巴管侵犯(LVI)会显著影响实性I期肺腺癌患者的无病生存期,但不会影响玻璃样不透明(GGO)腺癌患者的无病生存期。在I期肺腺癌中,实性腺癌中淋巴管侵犯(LVI)的发生率明显高于地玻璃不透明(GGO)阳性腺癌。LVI与实性腺癌或GGO腺癌患者的总生存率无关。
{"title":"The prognostic value of lymphovascular invasion for stage I lung adenocarcinoma based on the presence of ground-glass opacity","authors":"Jooae Choe, Sang Min Lee, Sohee Park, Sehoon Choi, Kyung-Hyun Do, Joon Beom Seo","doi":"10.1007/s00330-024-11048-0","DOIUrl":"https://doi.org/10.1007/s00330-024-11048-0","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Objectives</h3><p>There is still a debate regarding the prognostic implication of lymphovascular invasion (LVI) in stage I lung adenocarcinoma. Ground-glass opacity (GGO) on CT is known to correlate with a less invasive or lepidic component in adenocarcinoma, which may influence the strength of prognostic factors. This study aimed to explore the prognostic value of LVI in stage I lung adenocarcinoma based on the presence of GGO.</p><h3 data-test=\"abstract-sub-heading\">Materials and methods</h3><p>Stage I lung adenocarcinoma patients receiving lobectomy between 2010 and 2019 were retrospectively categorized as GGO-positive or GGO-negative (solid adenocarcinoma) on CT. Multivariable Cox regression analyses were performed for disease-free survival (DFS) and overall survival (OS) to evaluate the prognostic significance of pathologic LVI based on the presence of GGO.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Of 924 patients included (mean age, 62.5 ± 9.2 years; 505 women), 525 (56.8%) exhibited GGO-positive adenocarcinoma and 116 (12.6%) were diagnosed with LVI. LVI was significantly more frequent in solid than GGO-positive adenocarcinoma (20.1% vs. 6.9%, <i>p</i> &lt; 0.001). Multivariable analysis identified LVI and visceral pleural invasion (VPI) as significant prognostic factors for shorter DFS among solid adenocarcinoma patients (LVI, hazard ratio (HR): 1.89, <i>p</i> = 0.004; VPI, HR: 1.65, <i>p</i> = 0.003) but not GGO-positive patients (<i>p</i> = 0.76 and <i>p</i> = 0.87). In contrast, LVI was not a significant prognostic factor for OS in either group (<i>p</i> &gt; 0.05).</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>In stage I lung adenocarcinoma, pathologic LVI was associated with DFS only in patients with solid lung adenocarcinoma.</p><h3 data-test=\"abstract-sub-heading\">Clinical relevance statement</h3><p>Lymphovascular invasion (LVI) significantly affects disease-free survival in solid-stage I lung adenocarcinoma patients, but not those with ground-glass opacity (GGO) adenocarcinoma. Risk stratification considering both GGO on CT and LVI may identify patients benefiting from increased surveillance.</p><h3 data-test=\"abstract-sub-heading\">Key Points</h3><ul>\u0000<li>\u0000<p><i>The presence of ground-glass opacity portends different prognoses for lung adenocarcinoma.</i></p>\u0000</li>\u0000<li>\u0000<p><i>In stage I lung adenocarcinoma, lymphovascular invasion (LVI) was significantly more frequent in solid adenocarcinomas than in ground-glass opacity (GGO)-positive adenocarcinomas.</i></p>\u0000</li>\u0000<li>\u0000<p><i>LVI was not associated with overall survival in patients with either solid adenocarcinomas or GGO adenocarcinomas</i>.</p>\u0000</li>\u0000</ul>","PeriodicalId":12076,"journal":{"name":"European Radiology","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142264392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Radiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1